SCHEMBL19494409

SCHEMBL19494409

NC(=O)c1cc(SN2CCCCC2)sc1NC(=O)c1cnn2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 2/20 0.48
▸ NPC1 O15118 5/20 0.45
▸ RAB9A P51151 5/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ EPHB3 P54753 6/20 0.44
▸ RIPK2 O43353 1/20 0.44
▸ LCK P06239 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ KLF5 Q13887 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16246432 0.81 CFTR (0.59) IRAK4NPC1RAB9AALDH1A1EPHB3
SCHEMBL19494889 0.79 NPC1 (0.48) NPC1RAB9AALDH1A1KDM4ELMNA
SCHEMBL19494270 0.79 RAB9A (0.48) NPC1RAB9AALDH1A1KDM4ELMNA
SCHEMBL19494688 0.77 MAPT (0.52) NPC1RAB9AALDH1A1KDM4EHTT
SCHEMBL19494404 0.76 KAT6A (0.41) RAB9AALDH1A1KDM4ELMNAGAA
SCHEMBL19494403 0.75 RAB9A (0.52) NPC1RAB9AALDH1A1KDM4ELMNA
SCHEMBL19494581 0.73 CFTR (0.47) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL19494498 0.73 CFTR (0.40) RAB9AALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL19494323 0.72 CHEK1 (0.37) NPC1RAB9AALDH1A1KDM4EHTT
SCHEMBL19494684 0.70 NPC1 (0.46) NPC1RAB9AALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback